Navigation Links
VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
Date:12/17/2008

LEXINGTON, Ky., Dec. 17 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM), the nation's only proven Real-Time Prescription Monitoring System, announced today that it has appointed Anthony Bocchichio to its Advisory Board.

Mr. Bocchichio has over 37 years of experience in Federal drug law enforcement, 25 of which was spent with the Drug Enforcement Agency. He served as both Assistant Special Agent in Charge and Special Agent in Charge in Miami, FL and St. Louis, MO prior to taking the office of Assistant Administrator of the Operational Support Division of the DEA. Throughout his diverse career, Mr. Bocchichio has been responsible for the development and acquisition of new technology in order to better support the operational needs of the DEA. "I am very excited to be a part of such an innovative group of healthcare and technology professionals that make up the VirtualHealth team," says Mr. Bocchichio. "I look forward to sharing my insight into the challenges that face law enforcement in its fight to eliminate drug abuse and diversion."

Jim Renfro, VirtualHealth's President, was quoted as saying, "Anthony is just the right person we need to help provide guidance to our organization as we continue the enhancements to Veriscrip(TM) and in the continuing development of our security applications in Envoii Healthcare." VirtualHealth established its advisory board in an effort to bring in professionals from the various industries it serves that will assist in the successful execution of VirtualHealth's business goals.

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors, including, but not limited to assumptions, beliefs and opinions relating to the business and growth strategy of VirtualHealth Technologies, Inc. and its wholly owned subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, LLC, Medical Office Software, Inc. and implementation thereof, based upon the Company's interpretation and analysis of financial and market conditions, the decisions of businesses with whom the Company is either engaged in business with or negotiating, healthcare industry trends and management's ability to successfully finance, develop, market, sell and implement its e-commerce and internet solutions, clinical and financial e-transaction services and software applications to physicians, pharmacies, governmental agencies, laboratories, insurance companies, HMOs, and payers. These factors and other risk factors are more fully discussed in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any intent or obligation to update any forward-looking statements.

    Contact:  Shareholder Relations
    VirtualHealth Technologies, Inc.
    325 West Main Street, Suite 240
    Lexington, KY 40507
    (859) 455-9255
    Email: Shareholder.Relations@virtualhealthtechnologies.com
    Website: www.virtualhealthtechnologies.com

'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. VirtualHealth Technologies, Inc. Announces Management Appointment
2. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
3. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
4. VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
7. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
8. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
9. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
10. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
11. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased ... network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves ... exciting addition to our provider network, and the addition will benefit our members ...
(Date:1/17/2017)... ... January 17, 2017 , ... SensorInsight ®, ... Sigfox in the U.S.A. to offer Internet of Things (IoT) solutions based ... large-scale environmental sensor deployments such as monitoring solutions used to detect potentially hazardous ...
(Date:1/17/2017)... Baltimore, MD (PRWEB) , ... January 17, 2017 , ... ... joined the firm as a Principal in its IT Advisory Services practice . ... in recent months as market demand for strategic IT guidance grows, and the practice ...
(Date:1/17/2017)... ... 17, 2017 , ... Physicians Education Review®, LCC (PER®) announces ... for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 at ... Talamo, said, “We are delighted to have Sandra Lee join us as our ...
(Date:1/17/2017)... ... , ... Many people make New Year’s resolutions or renew their commitment to better health with ... for people who want to kick off 2017 with better smiles. Dr. Mondavi is offering ... special offers include: , , A new patient package for just ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan. 17, 2017 The Global ... of around 8.2% over the next decade to reach ... trends that the market is witnessing include rapidly growing ... recent technological advancements in nebulizer products and online marketing ... type the market is categorized into pneumatic nebulizers, ultrasonic ...
(Date:1/17/2017)... Jan. 17, 2017  Jazz Pharmaceuticals plc (Nasdaq: ... been enrolled in a Phase 3 clinical trial comparing ... care (BSC) in the prevention of hepatic veno-occlusive disease ... cell transplant (HSCT) who are at high risk or ... clinical trial will be conducted across approximately 100 medical ...
(Date:1/17/2017)... According to a new market research report "Neural Network Software Market by Type (Data ... - Global Forecast to 2021" published by MarketsandMarkets, the market to expand from ... Compound Annual Growth Rate (CAGR) of 33.2%. Continue ... ... ...
Breaking Medicine Technology: